One Stop Shop for All Your Market Research Reports

Global Primary Progressive Multiple Sclerosis Market Threats, Analysis, Key Players, Growth, and Forecast 2026

Global Primary Progressive Multiple Sclerosis Market is Propelled by Increasing R&D Expenditure by Market Players Multiple sclerosis (MS) also referred to as disseminated sclerosis, is an inflammatory disease of the nervous system. It is mainly characterized by the disruption of the nerve cells of the spinal cord and the brain of an affected individual, which results in the loss of ability to communicate along with various other physical, mental as well as psychiatric problems. Primary progressive multiple sclerosis (PPMS) is a type of MS in which the neurological functioning steadily deteriorates with no distinct relapses or fixed period of remissions. Only 10% - 15% of the total multiple sclerosis(MS) patients are diagnosed with primary progressive multiple sclerosis (PPMS). The rate of progression of PPMS may differ from person to person as well as over time. Signs of temporary improvement may be visible but the disease progression remains consistent. High prevalence of neurological disorders and demand for advanced therapeutics for the treatment of primary progressive multiple sclerosis (PPMS) are key drivers driving the growth of global primary progressive multiple sclerosis market. Increasing awareness among general population and availability of affordable medication for the treatment of PPMS are other major factors responsible for growth of the global primary progressive multiple sclerosis (PPMS) market. However, inaccurate methods for diagnosis and treatment of primary progressive multiple sclerosis (PPMS), is a major restraint for the growth of global primary progressive multiple sclerosis (PPMS) market. Awareness among the general population and unavailability of proper treatment in remote areas are some restraining factors for the growth of primary progressive multiple sclerosis market. As incidence of primary progressive multiple sclerosis is growing, demand for advanced therapeutics for the treatment of PPMS is at an all-time high. This untapped demand from emerging economies provides an opportunity for growth of the global primary progressive multiple sclerosis(PPMS) market. North America and Europe are expected to dominate the global primary progressive sclerosis(PPMS) market, owing to high demand of therapeutic drugs and effective treatment of PPMS in these geographies. According to multiple sclerosis portal, 0.5 million people are affected with multiple sclerosis in Europe and 0.4 million people affected population is present in the United States. Asia Pacific is expected to grow at a much faster pace over the forecast period, due to rising awareness among people and growth in emerging economics like India and China. Global primary progressive multiple sclerosis market segmentation by types of treatment:
  • Magnetic Resonance Imaging (MRI) Scans
  • Simple electrical stimulation tests
  • Lumbar puncture
Global primary progressive multiple sclerosis market segmentation by location of treatment:
  • Hospital testing
    • Commercial/private hospitals
    • Public health hospitals
    • Symptomatic diagnostic testing with medications
  • Clinics
  • Home Treatment
    • Managing symptoms
    • Rehabilitation
    • Healthy living
Global primary progressive multiple sclerosis market segmentation by region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Key players in the global primary progressive multiple sclerosis (PPMS) market includes,
  • Hoffmann-La Roche Ltd.
  • Innate Immunotherapeutics Ltd.
  • Teva Pharmaceutical Industries
  • Roche
  • Genzyme Corporation
  • Glialogix, Inc.
  • Kyorin Pharmaceutical Co., Ltd.
  • MedDay SA
  • Santhera Pharmaceuticals Holding AG
  • AB Science
Report Structure: In the first section of the report we offer a table of content, followed by a list of figures. The next section offers a definition and brief explanation of the various products and segmentation of the target market, along with research methodology and a list of acronyms and sources used to gather and analyse data and information. The third section of the report entails a brief list of drivers, restraints, opportunities, and threats (DROTs) in the target market. The report also offers insights on various trends in regions, countries, and markets as per segmentation, as well as insights and crucial information obtained from various sources including primary and secondary, annual reports, the Internet and others. The final section comprises detailed profiles of key players in the target market and a SWOT analysis of each company, apart from strategies, acquisitions and mergers. Objective of Report: Sections of the report are created and designed specifically to offer readers a clear, clean, and insights into historical, estimated, and revenue (US$ Mn/Bn) estimation and projection, Compounded Annual Growth Rate (CAGR %), and volume in measure as applicable to the target product/market. We offer illustrations, charts, tables, and figures to support our findings and analysis, in addition to key finding for markets in regions and countries. This report is valuable asset for the existing players, new entrants and the future investors. Who we are and what we do: Market.biz is a pioneering company in the fields of market research and analytical reporting. Our services enable clients to enhance business efficiency and focus on other core aspects of operations, while we take care of market research and reporting needs. Market.biz conducts and executes detailed and in-depth research and analysis across all relevant domains and offers accurate and insightful estimations and forecasts to enable clients to take well-informed and crucial decisions in their respective industries, sectors, or companies. Market.biz has access to the world’s most comprehensive and up-to-date databases in any business sector, as we understand the specific and varying needs of our clients. We offer updated reports to keep up with the changing scenarios in global markets and strive to ensure that only the utmost quality is established and maintained in every single report we produce. Our reports are conveniently designed and structured and are visually-pleasing. We provide a detailed analysis outlook of competitive markets and identify and study new and emerging trends and other crucial aspects and factors impacting or driving market growth. We also offer insights regarding new and emerging opportunities in the market and present the information in a comprehensive report focused on your respective market or sector.
Request for Table of Contents

Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ $ 4395
Multi User US $6395
Corporate User US $9395
About this Report
Report ID 148412
Category
  • Medical Devices
Published on Upcoming
Number of Pages NA
Publisher Name Prudour
Editor Rating
★★★★★
★★★★★
(0)